Related Experiment Video
Updated: Jun 30, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
Vascular dementia: From pathobiology to emerging perspectives.
Amy Elizabeth Morgan1, Mark Tomás Mc Auley2
1School of Health and Sports Sciences, Hope Park, Liverpool Hope University, Liverpool L16 9JD, United Kingdom.
Ageing Research Reviews
|March 21, 2024
Summary
Vascular dementia (VaD) is a common condition in aging. This review explores modifiable lifestyle factors and emerging treatments like epigenetics to reduce VaD risk and improve health outcomes for older adults.
Area of Science:
- Gerontology
- Neuroscience
- Pathobiology
Background:
- Vascular dementia (VaD) is the second most common dementia type, significantly impacting older adults' health.
- While risk factors are known, the exact pathological mechanisms of VaD require further elucidation.
- There is a need to identify modifiable lifestyle factors to mitigate VaD development risk.
Purpose of the Study:
- To critically examine factors influencing vascular dementia risk.
- To provide an overview of the pathobiology of VaD.
- To discuss emerging therapeutic strategies for VaD.
Main Methods:
- Literature review of studies on VaD risk factors and mechanisms.
- Analysis of research on lifestyle modifications and their impact on VaD.
- Exploration of novel treatment avenues such as epigenetics, gut microbiome, and pro-longevity drugs.
Main Results:
- Identified several modifiable lifestyle factors that can influence VaD risk.
- Provided insights into the underlying pathological mechanisms of VaD.
- Highlighted emerging treatments with potential to mitigate VaD.
Conclusions:
- Understanding VaD pathobiology and risk factors is crucial for prevention.
- Modifiable lifestyle factors offer a promising avenue for reducing VaD incidence.
- Emerging treatments like epigenetics and microbiome interventions warrant further investigation for VaD management.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Regulation of Stroke Volume
3.2K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.2K

